Jane Street Group, LLC Edwards Lifesciences Corp Call Options Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$101.96 - $128.34 $6.47 Million - $8.15 Million	63,500 Added 44.25%	207,000 $24.4 Million
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $10.5 Million - $12.9 Million	-99,000 Reduced 40.82%	143,500 $18.6 Million
Q3 2021 Nov 16, 2021	SELL	$102.91 - $122.75 $22.6 Million - $27 Million	-219,800 Reduced 47.54%	242,500 $27.5 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $26.9 Million - $33.7 Million	321,300 Added 227.87%	462,300 $47.9 Million
Q1 2021 May 18, 2021	BUY	$78.68 - $90.67 $2.08 Million - $2.39 Million	26,400 Added 23.04%	141,000 $11.8 Million
Q4 2020 Feb 17, 2021	SELL	$71.69 - $91.23 $1.4 Million - $1.78 Million	-19,500 Reduced 14.54%	114,600 $10.5 Million
Q3 2020 Nov 17, 2020	BUY	$67.19 - $87.44 $3.34 Million - $4.35 Million	49,700 Added 58.89%	134,100 $10.7 Million
Q2 2020 Aug 17, 2020	BUY	$57.54 - $76.95 $1.67 Million - $2.23 Million	29,000 Added 52.35%	84,400 $5.83 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $1.15 Million - $1.78 Million	22,000 Added 65.87%	55,400 $10.5 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $1.16 Million - $1.33 Million	16,200 Added 94.19%	33,400 $7.79 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $781,685 - $957,961	-12,700 Reduced 42.47%	17,200 $3.78 Million
Q2 2019 Aug 15, 2019	SELL	$55.74 - $64.41 $317,718 - $367,137	-5,700 Reduced 16.01%	29,900 $5.52 Million
Q1 2019 May 16, 2019	BUY	$47.89 - $64.05 $1.04 Million - $1.39 Million	21,700 Added 156.12%	35,600 $6.81 Million
Q4 2018 Feb 15, 2019	SELL	$46.41 - $56.94 $779,688 - $956,592	-16,800 Reduced 54.72%	13,900 $2.13 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $964,270 - $1.22 Million	21,100 Added 219.79%	30,700 $5.35 Million
Q2 2018 Aug 15, 2018	SELL	$42.45 - $51.3 $585,810 - $707,940	-13,800 Reduced 58.97%	9,600 $1.4 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $602,478 - $768,690	16,200 Added 225.0%	23,400 $3.27 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $261,288 - $279,576	7,200	7,200 $787,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account